Total Funding
44
48
Total FundingSeries B raised
Growth Score
1 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
14082
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
- Xiao Shang: CTO
Zhu Chen: Chief Scientific Officer
About the Company
ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug
candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages.
